In a new interview with United Cannabis Corp. (CNAB), Tony Verzura, the Company’s Chief Technology Officer and Chadwick Ruby, Chief Operating Officer for CNAB, discuss the recent news and events for the Company. Recently CNAB announced that it has signed a ten-year, exclusive licensing and distribution agreement with Amsterdam-based DNA Genetics. Prior to that the Company announced that it has filed for provisional patents related to the unique combinations of pharmaceutically active cannabinoids used to treat disorders of the nervous system, immune system and cancer with the U.S. Patent and Trademark Office.
United Cannabis Corporation was formed to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible. The Company’s A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution designed to enable physicians and patients to design, implement and monitor effective therapy protocols.
For further information, please visit www.unitedcannabis.us